Company / Cash & Equivalents
Ardent Health, Inc. Cash & Equivalents History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$709.6M
FY2025
5-year range
$437.6M / $709.6M
FY2023-FY2025
Trend
+27.4%
vs FY2024
Sector context
#37 of 148
Health Care
What the data says
Ardent Health, Inc.'s cash & equivalents of $710M is higher than 75% of companies in the Health Care sector (FY2025). Improved from $438M to $710M over the past 2 years.
Based on SEC 10-K filings.
$710M in FY2025. Top quartile in the Health Care sector.
Improved from $438M to $710M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 148This company $709.6M Sector average $1.2B
▼
-39.7% below sector average
Key checks
Key Insights
- In FY2025, cash & equivalents increased 27.4% year-over-year.
- Ranks #37 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $709.6M | +27.4% |
| FY2024 | $556.8M | +27.2% |
| FY2023 | $437.6M | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 24, 2026